Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study

Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study

To determine phenotype-related dupilumab response in adult patients with atopic dermatitis (AD), this multicenter, retrospective study included 111 adults with moderate-to-severe AD in Taiwan, with median age of 31.5 years (18–87) and 71 (64.0%) males. Patients received dupilumab 300 mg per two to t...

Full description

Bibliographic Details
Main Authors: Chin-Yi Yang, Po-Ju Lai, Chun-Bing Chen, Tom C. Chan, Rosaline Chung-Yee Hui, Yu-Huei Huang, Han-Chi Tseng, Shang-Hung Lin, Chun-Wei Lu, Hua-En Lee, Jing-Yi Lin, Min-Hui Chi, Ming-Feng Tsai, Yih-Shiou Hwang, Chuang-Wei Wang, Chia-Yu Chu, Wen-Hung Chung
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
atopic dermatitis
biomarker
dupilumab
eczema phenotype
efficacy
Online Access:https://www.mdpi.com/2077-0383/11/20/6209

Internet

https://www.mdpi.com/2077-0383/11/20/6209

Similar Items